Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)

Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)

Submitted by admin on July 9, 2018 - 10:56am
Source: 
GoinPharma
News Tags: 
France
Abivax
ABX464-005
HIV
Headline: 
Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)
snippet: 

The positive momentum of French biotech companies continues: Paris-based biotech Abivax this week has announced the top line data from a phase IIa trial assessing ABX464-005, a HIV therapy. 

Do Not Allow Advertisers to Use My Personal information